price feb usd
construct thesi predic balanc msd revenu
growth continu oper profit gain drive hsd earn
growth coupl return robust sharehold
yield double-digit total sharehold return trend
born overal good robust late-stag pipelin across
busi momentum look sustain forecast period
made modest upward revis ep estim chang
thesi reaffirm buy rate rais pt
valuation/risk pt updat ftm earn
estim henc multipl line
share recent trade forward earn forese
maintain provid continu achiev growth/margin/earn target
risk includ share loss key categori pipelin setback failur achiev
revenu highlight segment
segment highlight cvg sale cc came bit
factset consensu line crhf
csh tad light apv ahead think
icd includ crt-d us msd ou convent icd
pacemak ex-linq us low singl digit ou hsd continu
market out-performance driven micra tcp meaning revenue/
share impact dual-chamb physician advisori issu januari
subsequ class fda recal subsequ post last week
materi impact foreseen howev margin dilut near-term
owe swap impact devic eld develop
hvad us ww due previous
note issu relat guidelin chang impact overal market us
coupl earlier-than-expect approv
distribut gmt
deutsch bank seek busi compani cover research report thu investor
awar rm may conict interest could aect object report investor consid
report singl factor make invest decis disclosur analyst certif
dt indic hvad share drop growth
pressur persist next sever quarter
af sustain solid mid-teen growth continu uptak
cryoablat recent acquisit enabl foray
tavr market growth us ou
de above-market lsd growth us fuel resolut onyx ww lsd
apv venas post strong mid-teen growth paclitaxel dcb
headwind neg jaha meta-analysi look less dramatic/
last fear mid-teen pact admir growth
segment outlook segment revenu guidanc unchang
model cc revenu growth
key late-break march tavr low-risk tyrx
proprietari anti-bacteri envelop implant
launch evolut next-gen tavr valv
reveal linq bluetooth connect batteri life addit
paramet
launch new polari line crt-d system
micra av leadless pacer approv ye substanti expand
address market pacer popul versu current
fda approv av stula indic admir dcb
segment highlight mitg revenu cc outperform
consensu surgic innov
perform better expect
advanc energi ldd growth driven ligasur vessel seal
instrument valley lab energi system
advanc stapl hsd growth driven tri-stapl endoscop
stapl reload signia stapler
respiratori gi renal notabl strength base balanc growth gi
msd respiratori hsd ventil puls ox renal grew mid-
segment outlook segment guidanc increas vs
model
rearm expect surgic robot launch
time specic provid note resubmiss meet fda
regulatori agenc surgeon use system
collabor physician societi establish guidelin system
segment highlight sale cc slightli ahead
consensu brain therapi notabl strong pain therapi
under-perform rel model
brain therapi notabl strength driven high teen growth
neurosurgeri neurovascular neurosurgeri driven princip
capit equip stealthstat navig mazor robot o-
arm imag neurovascular strength broad-bas driven stroke
manag similarli strong perform seen nv
busi expect market remain high-growth next
sever year given high preval low penetr
pain therapi hsd pain stim growth fuel continu intelli
strength though appear lost share increasingli
competit market msd growth intervent pain kyphon
perform continu improv
spine revenu importantli apples-to-appl growth
spine compani combin spine-rel technolog
brain neurosurgeri healthi includ us spine
specialti therapi driven strength ent msd
transform solut mid-teen look ahead model
contempl inroad axon sn incontin
market current competit particularli light
posit top-lin data releas us pivot trial
morn note develop next-gener system
mitig competit advantag
segment outlook segment guidanc increas third consecut quarter
model
next-gener interstim sn system compat full-bodi mri
db continu develop closed-loop system specic time
undisclos cranial-mount db implant time also undisclos
segment highlight diabet sale cc meaning
consensu
continu momentum mask dicult comp due earlier-than-
expect fda approv
fda announc morn breakthrough design person
closed-loop system featur real-tim person algorithm
autom appropri insulin deliveri predict diagnost
segment outlook guid attish growth due aforement
comp issu growth remain well corpor averag
model
next-gen cgm launch
guardian sensor ling non-inject segment earli
margin earn perform
gm yr/yr model
om yr/yr meaning ahead
estim owe princip nice sg leverag sale vs
also lower vs model ebit
margin reect improv vs
ep comfort ahead consensu out-performance
versu driven mainli revenu beat lower tax rate
revenu light momentum organ revenu guidanc
narrow upper half prior rang impli
growth rang model growth
full year
ep margin target track ep guidanc nudg
light beat project earn
guidanc call gener nice midpoint
versu prior rang estim right midpoint guidanc
guidanc forthcom may call howev manag
express comfort current consensu ep continu
contempl up tax rate though believ tax mitig eort
princip ou debt restructur could result moder tax rate
model februari numbersnorth americaunit statesmed suppli devicesmedtronicreut nbloomberg usbuypric feb week cap profilemedtron lead player devic industri withleadership posit market compani sprimari product includ pacemak icd crt devic heart valv coronari stent spinal devic insulin pump neurostimul devic implant drug pump price performancemedtron rebas jul trendsebitda marginebit profitibilitysal growth lh roe debt/equ lh net interest cover year summarydb ep ep metricsprice/sal db report yield yield statement usdm flow cash raised/ bought inc/ dec investing/financ cash cash work sheet usdm cash plant sharehold compani metricssal growth ep growth ratio margin margin debt/equ interest cover analysisebit margin asset turnov financi cost ratio tax effect roa post tax financi leverag roe growth nta/shar average report growth compani data deutsch bank estim februari
price current end previou trade session unless otherwis indic sourc local exchang via reuter bloomberg vendor
inform sourc deutsch bank subject compani sourc disclosur pertain recommend estim made secur
primari subject research pleas see recent publish compani report visit global disclosur look-up page websit http //research db com/
research/disclosures/companysearch asid within report import risk conict disclosur also found http //research db com/research/topics/equ
investor strongli encourag review inform invest
import disclosur requir regul
disclosur mark asterisk may also requir least one jurisdict addit unit state see
import disclosur requir non-u regul explanatori note
within past year deutsch bank and/or aliat manag co-manag public privat
oer compani receiv fee
deutsch bank and/or aliat receiv compens compani provis
invest bank nancial advisori servic within past year
deutsch bank and/or aliat expect receiv intend seek compens invest bank
servic compani next three month
deutsch bank and/or aliat receiv non-invest bank relat compens
compani within past year
compani client deutsch bank secur inc within past year time
import disclosur requir non-u regul
disclosur mark asterisk may also requir least one jurisdict addit unit state see
import disclosur requir non-u regul explanatori note
within past year deutsch bank and/or aliat manag co-manag public privat
oer compani receiv fee
deutsch bank and/or aliat receiv compens compani provis
invest bank nancial advisori servic within past year
disclosur pertain recommend estim made secur primari subject
research pleas see recent publish compani report visit global disclosur look-up page websit
http //research db com/research/disclosures/companysearch
view express report accur reect person view undersign lead analyst
subject issuer secur issuer addit undersign lead analyst receiv
compens provid specic recommend view report pito chicker
histor recommend target price mdt
equiti rate dispers bank relationship
buy base current month view total share-hold
return tsr percentag chang share price current
price project target price plu pro-ject dividend yield
recommend investor buy stock
sell base current view total share-hold
return recommend investor sell stock
hold take neutral view stock
base time horizon recommend either buy
sell
newli issu research recommend target price
recommendationsbuyholdsellnot ratedsuspend rate analyst longer atdeutsch bankdatesecur target price chang usd kristen target price chang usd pito target price chang usd kristen target price chang usd pito chicker februari
inform opinion report prepar deutsch bank ag one aliat collect
deutsch bank though inform herein believ reliabl obtain public sourc
believ reliabl deutsch bank make represent accuraci complet hyperlink third-
parti websit report provid reader conveni deutsch bank neither endors content
respons accuraci secur control websit
use servic deutsch bank connect purchas sale secur discuss report
includ discuss anoth commun oral written deutsch bank analyst deutsch bank may
act princip account agent anoth person
deutsch bank may consid report decid trade princip may also engag transact
account custom manner inconsist view taken research report other within
deutsch bank includ strategist sale sta analyst may take view inconsist taken
research report deutsch bank issu varieti research product includ fundament analysi equity-link
analysi quantit analysi trade idea recommend contain one type commun may dier
recommend contain other whether result dier time horizon methodolog perspect
otherwis deutsch bank and/or aliat may also hold debt equiti secur issuer write
analyst paid part base protabl deutsch bank ag aliat includ invest
bank trade princip trade revenu
opinion estim project constitut current judgment author date report
necessarili reect opinion deutsch bank subject chang without notic deutsch bank provid
liquid buyer seller secur issu compani cover deutsch bank research analyst sometim
shorter-term trade idea may inconsist deutsch bank exist long-term rate trade
idea equiti list catalyst call research websit http //research db com/research/
found gener coverag list also cover compani page catalyst call repres high-convict
belief analyst stock outperform under-perform market and/or speci sector time frame
less two week three month addit catalyst call analyst may occasion discuss
client deutsch bank salesperson trader trade strategi idea refer catalyst
event may near-term medium-term impact market price secur discuss report
impact may direct counter analyst current view total return invest return
describ herein deutsch bank oblig updat modifi amend report otherwis notifi recipi
thereof opinion forecast estim chang becom inaccur coverag frequenc chang
market condit gener company-spec econom prospect make dicult updat research
dene interv updat sole discret coverag analyst research depart manag
major report publish irregular interv report provid inform purpos
take account particular invest object nancial situat need individu client
oer solicit oer buy sell nancial instrument particip particular trade strategi
price inher imprecis product analyst judgment nancial instrument discuss
report may suitabl investor investor must make inform invest decis
price avail nancial instrument subject chang without notic invest transact lead
loss result price uctuat factor nancial instrument denomin currenc
investor currenc chang exchang rate may advers aect invest past perform
necessarili indic futur result perform calcul exclud transact cost unless otherwis indic
unless otherwis indic price current end previou trade session sourc local
exchang via reuter bloomberg vendor data also sourc deutsch bank subject compani
parti
deutsch research depart independ busi divis detail regard
organiz arrang inform barrier prevent avoid conict interest respect
research avail websit http //research db com/research/ disclaim
macroeconom uctuat often account risk associ exposur instrument promis
pay xed variabl interest rate investor long xed-rat instrument thu receiv cash
ow increas interest rate natur lift discount factor appli expect cash ow thu
caus loss longer matur certain cash ow higher move discount factor
higher loss upsid surpris inat scal fund need fx depreci rate among
common advers macroeconom shock receiv counterparti exposur issuer creditworthi client
segment regul includ chang asset hold limit dierent type investor chang tax
polici currenc convert may constrain currenc convers repatri prot and/or liquid
posit settlement issu relat local clear hous also import risk factor sensit xed-
incom instrument macroeconom shock may mitig index contract cash ow inat
fx depreci speci interest rate common emerg market index xing may
construct lag mis-measur actual move underli variabl intend track choic
proper xing metric particularli import swap market oat coupon rate coupon index
typic short-dat interest rate refer index exchang xed coupon fund currenc dier
currenc coupon denomin carri fx risk option swap swaption risk typic
option addit risk relat rate movement
deriv transact involv numer risk includ market counterparti default illiquid risk
appropri product use investor depend investor circumst includ
tax posit regulatori environ natur asset liabil investor
take expert legal nancial advic enter transact similar inspir content
public risk loss futur trade option foreign domest substanti result
high degre leverag obtain futur option trade loss may incur greater
amount fund initi deposit theoret unlimit loss trade option involv risk
suitabl investor prior buy sell option investor must review characterist risk
standard option http //www optionsclear com/about/publications/character-risk jsp unabl
access websit pleas contact deutsch bank repres copi import document
particip foreign exchang transact may incur risk aris sever factor includ follow
exchang rate volatil subject larg uctuat ii valu currenc may aect numer
market factor includ world nation econom polit regulatori event event equiti debt market
chang interest rate iii currenc may subject devalu government-impos exchang control
could aect valu currenc investor secur adr whose valu aect
currenc underli secur eectiv assum currenc risk
unless govern law provid otherwis transact execut deutsch bank entiti
investor home jurisdict asid within report import conict disclosur also found
